Would you offer adjuvant olaparib to a male patient with HR+, HER2- T2N0 breast cancer with a BRCA2 germline mutation following mastectomy who is not a candidate for adjuvant chemotherapy?  

Medical Oncologist

Answer from: Medical Oncologist at Community Practice
Medical Oncologist at Kaiser Permanente Washington
Thanks for your input. This is an elderly patient ...
Medical Oncologist at Private Practice and Digital Health
With significant comorbidities and competing risks...
Sign in or Register to read more